Dry Eye Disease (DED) Clinical Trials

13 recruiting

Dry Eye Disease (DED) Trials at a Glance

13 actively recruiting trials for dry eye disease (ded) are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Newport Beach, Memphis, and Bloomington. Lead sponsors running dry eye disease (ded) studies include Chen Wei, China Medical University Hospital, and Aston University.

Browse dry eye disease (ded) trials by phase

Treatments under study

About Dry Eye Disease (DED) Clinical Trials

Looking for clinical trials for Dry Eye Disease (DED)? There are currently 13 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Dry Eye Disease (DED) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Dry Eye Disease (DED) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting
Phase 2Phase 3

A Clinical Study Evaluating Licaminlimab for Dry Eye Disease

Dry Eye Disease (DED)
Oculis160 enrolled10 locationsNCT07548632
Recruiting
Phase 4

SYSTANE® PRO vs. MIEBO™ in Dry Eye Disease

Dry Eye Disease (DED)
Indiana University260 enrolled4 locationsNCT07243275
Recruiting
Phase 4

A Non-interventional Study to Evaluate the Anti-inflammatory Effects and the Clinical Efficacy of Topical Water Free Cyclosporin 0.1% Eye Drops in Patients With Dry Eye Disease and Associated Ocular Surface Inflammation Non-responding to Artificial Tears: the FOCUS Study

Dry Eye Disease (DED)
Medical University of Vienna25 enrolled1 locationNCT07463950
Recruiting
Not Applicable

Clinical Investigation Between the Topical Administration of a Tear Substitute With Ancillary Medicinal Substance and Hyaluronic Acid 0.3% (FBV_01) vs Hyaluronic Acid 0.3% in Subjects in the Treatment From Moderate to Severe DED

Dry Eye Disease (DED)Dry Eye Syndromes
FB Vision S.p.A74 enrolled2 locationsNCT07412860
Recruiting
Phase 4

Supplementary Kelulut Honey Therapy in Juvenile Open-Angle Glaucoma: Effects on IL-6, RNFL and Dry Eye

Juvenile Open Angle GlaucomaDry Eye Disease (DED)Interleukin 6+2 more
Universiti Sains Malaysia60 enrolled4 locationsNCT07396441
Recruiting
Not Applicable

Impact of Tixel Treatment on Symptoms and Signs in Patients With Dry Eye Disease

Dry Eye Disease (DED)
Aston University36 enrolled1 locationNCT06615453
Recruiting
Phase 4

New Preservative-free Combination of Trehalose, Sodium Hyaluronate and N-acetyl-aspartyl-glutamate (NAAGA) in Dry Eye

Dry Eye Disease (DED)
Laboratoires Thea30 enrolled1 locationNCT06903741
Recruiting
Not Applicable

Evaluating Crosslinked Hyaluronate Canalicular Gel for the Treatment of DED in Patients Undergoing Cataract Surgery

Dry Eye Disease (DED)
Vance Thompson Vision60 enrolled1 locationNCT07155057
Recruiting
Not Applicable

Proteomics Analysis of Human Tears in the Diagnosis and Management of Dry Eye Disease

Dry Eye Disease (DED)Dry Eye
The Hong Kong Polytechnic University75 enrolled1 locationNCT07175909
Recruiting
Not Applicable

Observe the Effects of Far Infrared Eye Masks on Acupoints Around the Eyes in Patients With Dry Eye Syndrome

Dry Eye Disease (DED)
China Medical University Hospital45 enrolled2 locationsNCT07060131
Recruiting

Telemedicine Evaluation of Dry Eye Disease Using a Portable Automatic Ocular Surface Imaging Device (PAOSID)

Dry Eye Disease (DED)
Chen Wei150 enrolled1 locationNCT06984549
Recruiting
Phase 3

Phase III Clinical Study of Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease

Dry Eye Disease (DED)
Lunan Better Pharmaceutical Co., LTD.820 enrolled1 locationNCT06879782
Recruiting

Role of Corneal Nerves in Dry Eye Disease

Dry Eye Disease (DED)Dry EyeDry Eye Sensation+1 more
Daniela Nosch140 enrolled1 locationNCT06841471